Dr. Lash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1430 Eagle Bend Dr
Southlake, TX 76092Phone+1 817-251-2040- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationFellowship, Gastrointestinal Pathology, 1987 - 1988
- Cleveland Clinic FoundationResidency, Pathology-Anatomic and Clinical, 1983 - 1987
- University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
- TX State Medical License 2005 - 2025
- NY State Medical License 2007 - 2025
- OH State Medical License 1987 - 2021
- FL State Medical License 2004 - 2020
- AZ State Medical License 2005 - 2019
- PA State Medical License 2003 - 2018
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Fellow (FCAP) College of American Pathologists, 1987
- AOA Alpha Omega Alpha Medical Society, 1982
- Fellow (AGAF) American Gastroenterological Association, 2012
Publications & Presentations
PubMed
- 28 citationsAbnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia.Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Marianne Rara, Diane Stapleton, Laurel Nowden, Richard H. Lash, Adam J. Bass, Matthew D. Stachler> ;Gastroenterology. 2021 Oct 29
- 86 citationsDetection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.Matthew D. Stachler, Nicholas D. Camarda, Christopher Deitrick, Anthony Kim, Agoston T. Agoston, Robert D. Odze, Jason L. Hornick, Anwesha Nag, Aaron R. Thorner, Matth...> ;Gastroenterology. 2018 Jul 1
- 15 citationsGene expression-phenotype associations in adults with eosinophilic esophagitis.Evan S. Dellon, Sara R. Selitsky, Robert M. Genta, Richard H. Lash, Joel S. Parker> ;Digestive and Liver Disease. 2018 Aug 1
- Join now to see all
Press Mentions
- Is Sixth Drug in InformTx™ Therapeutic Drug Monitoring Service from Miraca Life SciencesMarch 28th, 2017
- Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life SciencesDecember 1st, 2016
- EoGenius™ Test for Eosinophilic Esophagitis Launched by Miraca Life SciencesMarch 2nd, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: